Genetic variability of HIF1A and response to treatment with cisplatin in combination with pemetrexed or gemcitabine in patients with malignant mesothelioma Cover

.blurhash-client-img { display: none !important; }

Genetic variability of HIF1A and response to treatment with cisplatin in combination with pemetrexed or gemcitabine in patients with malignant mesothelioma

Radiology and Oncology

Volume 59 (2025): Issue 3 (September 2025)

By: Matic Setina, Eva Setina, Ziga Doljak, Katja Goricar, Vita Dolzan and Viljem Kovac

Open Access

|Sep 2025

Authors

Matic Setina

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Eva Setina

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Ziga Doljak

Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Katja Goricar

Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Vita Dolzan

Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Viljem Kovac

vkovac@onko-i.si

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Institute of Oncology Ljubljana, Ljubljana, Slovenia

DOI: https://doi.org/10.2478/raon-2025-0049 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Journal RSS Feed

Language: English

Page range: 403 - 411

Submitted on: Jun 15, 2025

|

Accepted on: Jul 19, 2025

|

Published on: Sep 5, 2025

Published by: Association of Radiology and Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

malignant mesothelioma,

hypoxia-inducible factor,

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology,

© 2025 Matic Setina, Eva Setina, Ziga Doljak, Katja Goricar, Vita Dolzan, Viljem Kovac, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous article Volume 59 (2025): Issue 3 (September 2025)Next article